Authors‘ reply to the letter to the editor by Fedai et al.: “Long-term safety and efficacy of pegvisomant monotherapy for acromegaly: final data from the full ACROSTUDY cohort”

Kevin C.J. Yuen; Sebastian Neggers; Thierry Brue

doi:10.1007/s11102-026-01722-5

Authors‘ reply to the letter to the editor by Fedai et al. “Long-term safety and efficacy of pegvisomant monotherapy for acromegaly: final data from the full ACROSTUDY cohort”

Kevin C.J. Yuen^*
, Sebastian Neggers
, Thierry Brue

^*Corresponding author for this work

Internal Medicine

University of Arizona
Marseille Medical Genetics

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Article number	118
Journal	Pituitary
Volume	29
Issue number	4
DOIs	https://doi.org/10.1007/s11102-026-01722-5
Publication status	E-pub ahead of print - 8 Jul 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/s11102-026-01722-5

Cite this

@article{687ed9cc45744b519c77452404f47b58,

title = "Authors{\textquoteleft} reply to the letter to the editor by Fedai et al.: {\textquotedblleft}Long-term safety and efficacy of pegvisomant monotherapy for acromegaly: final data from the full ACROSTUDY cohort{\textquotedblright}",

author = "Yuen, \{Kevin C.J.\} and Sebastian Neggers and Thierry Brue",

year = "2026",

month = jul,

day = "8",

doi = "10.1007/s11102-026-01722-5",

language = "English",

volume = "29",

journal = "Pituitary",

issn = "1386-341X",

publisher = "Springer",

number = "4",

}

Authors‘ reply to the letter to the editor by Fedai et al. “Long-term safety and efficacy of pegvisomant monotherapy for acromegaly: final data from the full ACROSTUDY cohort”. / Yuen, Kevin C.J.; Neggers, Sebastian; Brue, Thierry.
In: Pituitary, Vol. 29, No. 4, 118, 08.07.2026.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Authors‘ reply to the letter to the editor by Fedai et al.

T2 - “Long-term safety and efficacy of pegvisomant monotherapy for acromegaly: final data from the full ACROSTUDY cohort”

AU - Yuen, Kevin C.J.

AU - Neggers, Sebastian

AU - Brue, Thierry

PY - 2026/7/8

Y1 - 2026/7/8

UR - https://www.scopus.com/pages/publications/105044163456

U2 - 10.1007/s11102-026-01722-5

DO - 10.1007/s11102-026-01722-5

M3 - Comment/Letter to the editor

C2 - 42417906

AN - SCOPUS:105044163456

SN - 1386-341X

VL - 29

JO - Pituitary

JF - Pituitary

IS - 4

M1 - 118

ER -

Authors‘ reply to the letter to the editor by Fedai et al. “Long-term safety and efficacy of pegvisomant monotherapy for acromegaly: final data from the full ACROSTUDY cohort”

UN SDGs

Access to Document

Other files and links

Embargoed Document

Cite this